Human Microbiome-based Gut Health Test and Nutrition Market
完整報告名稱與涵蓋範圍
Human Microbiome-based Gut Health Test and Nutrition Market Size, Share & Trends Analysis Report By Product (D2C Gut Health Test, Probiotic Supplements, Personalized Nutrition, Microbiome Modulators), by End-User, By Region, And Segment Forecasts, 2024-2031
報告摘要
The global Human Microbiome-based Gut Health Test and Nutrition Market is set to witness notable expansion over the coming years.
Human Microbiome-based Gut Health Test and Nutrition encompasses known as human microbiomes. The sector has gained traction as organizations seek innovative approaches to address evolving industrial challenges.
The market's upward path is fueled by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in industrial.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Human Microbiome-based Gut Health Test and Nutrition Market Snapshot
Chapter 4. Global Human Microbiome-based Gut Health Test and Nutrition Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By End-Users Estimates & Trend Analysis
5.1. By End-Users & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-Users:
5.2.1. Adult
5.2.2. Maternal
5.2.3. Infant
Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis
6.1. By Products & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Products:
6.2.1. D2C Gut Health Test
6.2.2. Probiotic Supplements
6.2.3. Personalized Nutrition
6.2.4. Microbiome Modulators
6.2.4.1. Ingredients
6.2.4.2. Medical Foods
6.2.4.3. Therapeutics
Chapter 7. Human Microbiome-based Gut Health Test and Nutrition Market Segmentation 5: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts By End-Users, 2024-2031
7.1.2. North America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by Products, 2024-2031
7.1.3. North America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) By End-Users, 2024-2031
7.2.3. Europe Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by Products, 2024-2031
7.2.4. Europe Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) By End-Users, 2024-2031
7.3.3. Asia Pacific Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by Products, 2024-2031
7.3.4. Asia Pacific Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) by country, 2024-2031
7.4. Latin America
7.4.1. Latin America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) By End-Users, 2024-2031
7.4.3. Latin America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by Products, 2024-2031
7.4.4. Latin America Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) By End-Users, 2024-2031
7.5.3. Middle East & Africa Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) estimates and forecasts by Products, 2024-2031
7.5.4. Middle East & Africa Human Microbiome-based Gut Health Test and Nutrition Market revenue (US$ Million) by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Seed Health
8.2.2. ResBiotic
8.2.3. Fitbiomics
8.2.4. HSK Genetech
8.2.5. Mybacs
8.2.6. ISOThrive
8.2.7. Nouri
8.2.8. The Archer-Daniels-Midland Company (ADM)
8.2.9. Bayer Consumer Health
8.2.10. Clasado Biosciences
8.2.11. CometBio
8.2.12. Essential formulae
8.2.13. ExeGi
8.2.14. Kerry
8.2.15. Immune Biotech
8.2.16. Pendulum Therapeutics
8.2.17. Evolve Biosystems
8.2.18. Gerber
8.2.19. Lovebug probiotics
8.2.20. Mommy's Bliss
8.2.21. Zarbees
8.2.22. Mamasselect
8.2.23. Hyperbiotics
8.2.24. Everidis
8.2.25. Floraster
8.2.26. Enfamil
8.2.27. Culturelle
8.2.28. Biogaia
8.2.29. Viome
8.2.30. Atlas Biomed
8.2.31. Flore
8.2.32. Bioms
8.2.33. Ombre
8.2.34. Biohm
8.2.35. Affinity DNA
8.2.36. Freshly fermented
8.2.37. Carbiotix
8.2.38. Troo
8.2.39. Verisana
8.2.40. Throne
8.2.41. Phable
8.2.42. Biomesight
8.2.43. Invivo
8.2.44. Neovos
8.2.45. The BioArte
8.2.46. Bio & Me
8.2.47. Nexbiome
8.2.48. Finch therapeutics
8.2.49. Byheart
8.2.50. Mybiotics
8.2.51. Vedanta Biosciences
8.2.52. Holobiome
8.2.53. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們